Nanoparticles-Based Strategies to Improve the Delivery of Therapeutic Small Interfering RNA in Precision Oncology

Small interfering RNA (siRNA) can selectively suppress the expression of disease-causing genes, holding great promise in the treatment of human diseases, including malignant cancers. In recent years, with the development of chemical modification and delivery technology, several siRNA-based therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jinxing, Xiao, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415718/
https://www.ncbi.nlm.nih.gov/pubmed/36015212
http://dx.doi.org/10.3390/pharmaceutics14081586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415718/
https://www.ncbi.nlm.nih.gov/pubmed/36015212
http://dx.doi.org/10.3390/pharmaceutics14081586

Ejemplares similares